Adlyxin vs Soliqua
Drug comparison
Last updated 2026-05-28 15:46 UTCAdlyxin and Soliqua are both injectable medications for type 2 diabetes made by Sanofi, and both contain the active ingredient lixisenatide. The main difference is that Adlyxin is a standalone drug, while Soliqua combines lixisenatide with another diabetes medication called insulin glargine in a single injection.
AI summary of the sources below.
| Adlyxin | Soliqua | |
|---|---|---|
| Active ingredient | lixisenatide | lixisenatide |
| Manufacturer | sanofi | sanofi |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes |
| Label updated | — | 2026-03-18 |